Epigenetic-Like Stimulation of Receptor Expression in SSTR2 Transfected HEK293 Cells as a New Therapeutic Strategy

SIMPLE SUMMARY: Neuroendocrine tumors (NETs) expressing the somatostatin receptor subtype 2 (SSTR2) are promising targets for peptide receptor radionuclide therapy (PRRT) using the somatostatin analogue Lu-177-DOTATATE. Patients expressing low levels of SSTR2 do not benefit from PRRT. Therefore, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotzerke, Joerg, Buesser, Dorothee, Naumann, Anne, Runge, Roswitha, Huebinger, Lisa, Kliewer, Andrea, Freudenberg, Robert, Brogsitter, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140012/
https://www.ncbi.nlm.nih.gov/pubmed/35626117
http://dx.doi.org/10.3390/cancers14102513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140012/
https://www.ncbi.nlm.nih.gov/pubmed/35626117
http://dx.doi.org/10.3390/cancers14102513

Ejemplares similares